首页> 外国专利> METHOD FOR DETERMINING A REFERENCE TUMOR AGGRESSIVENESS MOLECULAR GRADIENT FOR A PANCREATIC DUCTAL ADENOCARCINOMA

METHOD FOR DETERMINING A REFERENCE TUMOR AGGRESSIVENESS MOLECULAR GRADIENT FOR A PANCREATIC DUCTAL ADENOCARCINOMA

机译:胰导管腺癌的参考肿瘤辅助给药分子梯度的测定方法

摘要

The present invention relates to a method for determining a reference tumor aggressiveness molecular gradient for at least one pancreatic ductal adenocarcinoma (PDAC) sample, to a method for determining a specific tumor aggressiveness molecular gradient from a plurality of particular PDAC samples, and to methods for determining a tumor aggressiveness of a PDAC sample to be diagnosed. The method for determining a reference tumor aggressiveness molecular gradient comprises: generating a first matrix of transcriptomic profiles from first vectors representing respectively reference transcriptomic profiles of tumor samples of human or animal origin; obtaining, for each reference transcriptomic profile, a tumor aggressiveness histological class; decomposing the first matrix by a matrix factorization method allowing an identification of at least partially decorrelated components; identifying a first component that is the most discriminating relatively to the tumor aggressiveness histological classes associated with the reference transcriptomic profiles; determining the reference tumor aggressiveness molecular gradient as a distribution of projections of the first vectors on the first component.
机译:本发明涉及一种用于确定至少一个胰腺导管腺癌(PDAC)样品的参考肿瘤侵袭性分子梯度的方法,一种用于从多个特定的PDAC样品中确定特定肿瘤侵袭性分子梯度的方法,以及用于确定要诊断的PDAC样品的肿瘤侵袭性。确定参考肿瘤侵袭性分子梯度的方法包括:从分别代表人或动物来源的肿瘤样品的参考转录组谱的第一载体产生转录组谱的第一矩阵;对于每个参考转录组谱,获得肿瘤侵袭性组织学类别;通过矩阵分解方法分解第一矩阵,该矩阵分解方法允许识别至少部分去相关的分量;鉴定相对于与参考转录组谱相关的肿瘤侵袭性组织学类别而言最具区别性的第一成分;确定参考肿瘤侵袭性分子梯度作为第一载体在第一组分上的投影分布。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号